Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease. The two investigators, Giulio Maria Pasinetti, M.D., Ph.D. , and Hillel Grossman, M.D., presented Phase IIA preliminary clinical findings at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD) in Vienna on Sunday, July 12.
- Mount Sinai researchers find new Alzheimer's disease treatment promisingSun, 12 Jul 2009, 7:28:36 EDT
- Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's diseaseFri, 10 Apr 2009, 11:42:41 EDT
- Diabetes gene linked to degeneration of enzyme involved in Alzheimer's disease onset and progressionTue, 12 Oct 2010, 15:33:01 EDT
- Mayo Clinic study continues to refine most effective methods to predict Alzheimer's diseaseTue, 14 Jul 2009, 9:23:04 EDT
- Indications of Alzheimer's disease may be evident decades before first signs of cognitive impairmentMon, 28 Mar 2011, 15:33:45 EDT